Lou A. Bianco
Directeur/Bestuurslid bij DiaKine Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Lou A. Bianco
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 42 | |
DiaKine Therapeutics, Inc.
 DiaKine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology DiaKine Therapeutics, Inc. is a start-up biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and complications related to diabetes. These drugs have the potential to restate the diabetes market by stopping the progression of diabetes and reversing damage already caused by the disease. Because of their unique immune modulating and anti-inflammatory properties, these therapies may potentially benefit people with type 1 and type 2 diabetes and represent a total available market opportunity of approximately $13 billion. The Company's lead compound, Lisofylline (LSF), has had an excellent safety profile in clinical trials to date. LSF works at the cellular level by improving the function of insulin producing islet cells and protecting them from damage and premature death caused when the body's immune system turns on itself. This autoimmune action is the cause of type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA), which combined affect approximately three million people in the U.S. About three million people with type 2 diabetes use insulin due to diminished insulin production and an increasing resistance to insulin. A primary focus of DiaKine's research and development is on its next generation of orally bioavailable immune modulators which have an improved spectrum of action to LSF. Two such compounds, DT22669 and DT23552, have been identified for further development and are examples of the extensive library of analogs and new structures in its patent portfolio that await discovery for future indications.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Deutsche Bank Capital Corp.
3
| Extinct | Investment Banks/Brokers | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Lou A. Bianco via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| The University of Chicago | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact Chief Tech/Sci/R&D Officer | |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Aequus BioPharma, Inc.
 Aequus BioPharma, Inc. Medical/Nursing ServicesHealth Services Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals. Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Graduate Degree Masters Business Admin | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Graduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| New York University | College/University | Undergraduate Degree Masters Business Admin | |
March of Dimes Foundation
 March of Dimes Foundation Miscellaneous Commercial ServicesCommercial Services March of Dimes Foundation is a non-profit organization for pregnancy and baby health. The organization works to improve the health of babies by preventing birth defects, premature birth, and infant mortality. March of Dimes Foundation was founded on January 3, 1938 and is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer General Counsel | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Director/Board Member | |
| Brown University | College/University | Undergraduate Degree President | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Public Communications Contact Director/Board Member | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Founder Investor Relations Contact | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Director/Board Member | |
Veterans Administration Medical Center
 Veterans Administration Medical Center Hospital/Nursing ManagementHealth Services Veterans Administration Medical Center provides healthcare services. The private company is based in San Diego, CA. | Hospital/Nursing Management | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| UNITEDHEALTH GROUP INC. | Managed Health Care | Director/Board Member Chief Tech/Sci/R&D Officer | |
BVF, Inc.
 BVF, Inc. Investment Banks/BrokersFinance BVF, Inc. manages engages in investment business and manages biotech focused hedge funds. The firm manages Biotechnology Value Fund LP and Biotechnology Value Fund II LP. The company was founded by Mark Nathan Lampert on September 14, 1993 and is headquartered in San Francisco, CA. | Investment Banks/Brokers | President | |
| Dartmouth College | College/University | Masters Business Admin | |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Investment Managers | President | |
| XOMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| Western Washington University | College/University | Undergraduate Degree | |
| John Marshall Law School (Georgia) | College/University | Graduate Degree | |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Director of Finance/CFO | |
Feinstein Kean Healthcare
 Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Feinstein Kean Partners, Inc.
 Feinstein Kean Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Ogilvy Government Relations, Feinstein Kean Partners, Inc. is a public relations firm. The company is based in Cambridge, MA. Feinstein Kean Partners was acquired by Ogilvy Public Relations Worldwide, Inc. on November 08, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| San Diego State University | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 50 |
| Italië | 2 |
Sectoraal
| Health Technology | 18 |
| Consumer Services | 16 |
| Commercial Services | 11 |
| Finance | 5 |
| Health Services | 4 |
Operationeel
| Director/Board Member | 186 |
| Corporate Officer/Principal | 116 |
| Chairman | 43 |
| Undergraduate Degree | 42 |
| President | 32 |
Sterkste connecties
| Insiders | |
|---|---|
| Erich Maximilian Platzer | 31 |
| Reed Tuckson | 31 |
| John Fluke | 30 |
| Herbert J. Scheidt | 26 |
| Frederick Telling | 23 |
| Richard L. Love | 23 |
| Stephen Aselage | 20 |
| James A. Bianco | 17 |
| Vartan Gregorian | 15 |
| Matthew J. Plunkett | 14 |
| Steven E. Benner | 13 |
| Michael Metzger | 13 |
| Phillip M. Nudelman | 12 |
| Jun Bao | 12 |
| Glenn C. Rice | 11 |
- Beurs
- Insiders
- Lou A. Bianco
- Bedrijfsconnecties
